SCHEMBL8993346

SCHEMBL8993346

COc1ccc(C2=C(c3ccc(S)cc3)CCC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.60
PTGS1 P23219 2/20 0.60
SLC6A3 Q01959 1/20 0.54
FGF23 Q9GZV9 1/20 0.53
ESR1 P03372 2/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
ESR2 Q92731 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
APP P05067 1/20 0.39
CYP1A2 P05177 2/20 0.39
BRD4 O60885 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2622585 0.88 PTGS2 (0.68) PTGS2PTGS1SLC6A3FGF23ESR1
SCHEMBL7243101 0.81 ESR2 (0.58) CA12CA1CA2CA7CA9
SCHEMBL13766500 0.81 PTGS2 (0.60) PTGS2PTGS1SLC6A3FGF23ESR1
SCHEMBL50514 0.78
SCHEMBL6512391 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
SCHEMBL5302598 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
Hydrogen Sulfide SCHEMBL27634199 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
SCHEMBL6521833 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
SCHEMBL28010058 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
SCHEMBL27744604 0.76 CA1 (0.65) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0724566-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011883-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-05-04 WO disclosed